Trial intelligence / Profile preview

Exenatide vs Insulin for Perioperative Glycemic Control in Cardiac Surgery

NCT01969149Phase 3Completed

Sponsor
CHU de Besançon
Start
Jan 2015
Primary completion
Dec 2015
Modality
Peptides
Countries
1
01

Overview

A Phase 3 trial of exenatide in Stress Hyperglycemia (SH), sponsored by CHU de Besançon. Started Jan 2015; status: completed.

02

Drugs

exenatide
03

Conditions

Stress Hyperglycemia (SH)

Beyond the preview

Go deeper on NCT01969149.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01969149.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call